Global Biologics Outsourcing Services 麻豆原创 Research Report 2024

Publication ID:

PB504243472

Publication Date:

April 9, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Biologics outsourcing services refer to the practice of pharmaceutical and biotechnology companies partnering with external organizations to handle various aspects of the development and manufacturing of biologic drugs. Biologics are complex therapeutic molecules produced using living organisms or their components, such as proteins, antibodies, or nucleic acids.
Outsourcing these services allows companies to leverage the expertise, infrastructure, and resources of specialized contract service providers, often referred to as Contract Development and Manufacturing Organizations (CDMOs) or Contract Research Organizations (CROs).
The global Biologics Outsourcing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The global demand for biologic drugs continued to rise, driven by factors such as the aging population, increasing prevalence of chronic diseases, and advancements in biotechnology. This heightened demand led to greater outsourcing of biologics development and manufacturing to specialized service providers.
The development and approval of biosimilar drugs, which are highly similar versions of approved biologic drugs, gained momentum. As biosimilars offer cost-effective alternatives to branded biologics, there was a growing need for outsourcing services to support biosimilar development, including analytical testing, process development, and manufacturing.
This report aims to provide a comprehensive presentation of the global market for Biologics Outsourcing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Outsourcing Services.
The Biologics Outsourcing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Outsourcing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Outsourcing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
Segment by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Outsourcing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Biologics Outsourcing Services 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell and Gene Therapies
1.2.3 Antibodies
1.2.4 Vaccines
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Biologics Outsourcing Services 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Outsourcing Services 麻豆原创 Perspective (2019-2030)
2.2 Global Biologics Outsourcing Services Growth Trends by Region
2.2.1 Global Biologics Outsourcing Services 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Outsourcing Services Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Biologics Outsourcing Services Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Biologics Outsourcing Services 麻豆原创 Dynamics
2.3.1 Biologics Outsourcing Services Industry Trends
2.3.2 Biologics Outsourcing Services 麻豆原创 Drivers
2.3.3 Biologics Outsourcing Services 麻豆原创 Challenges
2.3.4 Biologics Outsourcing Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Outsourcing Services Players by Revenue
3.1.1 Global Top Biologics Outsourcing Services Players by Revenue (2019-2024)
3.1.2 Global Biologics Outsourcing Services Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Biologics Outsourcing Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics Outsourcing Services Revenue
3.4 Global Biologics Outsourcing Services 麻豆原创 Concentration Ratio
3.4.1 Global Biologics Outsourcing Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Outsourcing Services Revenue in 2023
3.5 Global Key Players of Biologics Outsourcing Services Head office and Area Served
3.6 Global Key Players of Biologics Outsourcing Services, Product and Application
3.7 Global Key Players of Biologics Outsourcing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Outsourcing Services Breakdown Data by Type
4.1 Global Biologics Outsourcing Services Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Biologics Outsourcing Services Forecasted 麻豆原创 Size by Type (2025-2030)
5 Biologics Outsourcing Services Breakdown Data by Application
5.1 Global Biologics Outsourcing Services Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Biologics Outsourcing Services Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Biologics Outsourcing Services 麻豆原创 Size (2019-2030)
6.2 North America Biologics Outsourcing Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Outsourcing Services 麻豆原创 Size by Country (2019-2024)
6.4 North America Biologics Outsourcing Services 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Outsourcing Services 麻豆原创 Size (2019-2030)
7.2 Europe Biologics Outsourcing Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Outsourcing Services 麻豆原创 Size by Country (2019-2024)
7.4 Europe Biologics Outsourcing Services 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Outsourcing Services 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Biologics Outsourcing Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Outsourcing Services 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Outsourcing Services 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Outsourcing Services 麻豆原创 Size (2019-2030)
9.2 Latin America Biologics Outsourcing Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Outsourcing Services 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Biologics Outsourcing Services 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Outsourcing Services 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Biologics Outsourcing Services 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Outsourcing Services 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Outsourcing Services 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics Outsourcing Services Introduction
11.1.4 Lonza Revenue in Biologics Outsourcing Services Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Biologics Outsourcing Services Introduction
11.2.4 Catalent Revenue in Biologics Outsourcing Services Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics Biologics Outsourcing Services Introduction
11.3.4 Samsung Biologics Revenue in Biologics Outsourcing Services Business (2019-2024)
11.3.5 Samsung Biologics Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics Outsourcing Services Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Biologics Outsourcing Services Business (2019-2024)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biologics Outsourcing Services Introduction
11.5.4 Boehringer Ingelheim Revenue in Biologics Outsourcing Services Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Details
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Biologics Outsourcing Services Introduction
11.6.4 WuXi AppTech Revenue in Biologics Outsourcing Services Business (2019-2024)
11.6.5 WuXi AppTech Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Details
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Biologics Outsourcing Services Introduction
11.7.4 Recipharm Revenue in Biologics Outsourcing Services Business (2019-2024)
11.7.5 Recipharm Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Biologics Outsourcing Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Biologics Outsourcing Services Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 AGC Biologics
11.9.1 AGC Biologics Company Details
11.9.2 AGC Biologics Business Overview
11.9.3 AGC Biologics Biologics Outsourcing Services Introduction
11.9.4 AGC Biologics Revenue in Biologics Outsourcing Services Business (2019-2024)
11.9.5 AGC Biologics Recent Development
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Details
11.10.2 Rentschler Biopharma Business Overview
11.10.3 Rentschler Biopharma Biologics Outsourcing Services Introduction
11.10.4 Rentschler Biopharma Revenue in Biologics Outsourcing Services Business (2019-2024)
11.10.5 Rentschler Biopharma Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Details
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biologics Outsourcing Services Introduction
11.11.4 KBI Biopharma Revenue in Biologics Outsourcing Services Business (2019-2024)
11.11.5 KBI Biopharma Recent Development
11.12 Siegfried
11.12.1 Siegfried Company Details
11.12.2 Siegfried Business Overview
11.12.3 Siegfried Biologics Outsourcing Services Introduction
11.12.4 Siegfried Revenue in Biologics Outsourcing Services Business (2019-2024)
11.12.5 Siegfried Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Details
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Biologics Outsourcing Services Introduction
11.13.4 Aenova Group Revenue in Biologics Outsourcing Services Business (2019-2024)
11.13.5 Aenova Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi AppTech
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.